In a 2008 study, the ROC curves used to distinguish HCC from cirrhotic patients only showed that IL-6 titres had higher discriminant power than AFP titres, with a cut-off value of 12 pg/mL (sensitivity 0.73, specificity 0.87, efficiency 0.8). Here, IL6 is linked to hepatocellular carcinoma.